Veracyte (VCYT) Share-based Compensation Growth (3y) (2015 - 2026)
Veracyte (VCYT) Share-based Compensation Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 3.48% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | -1.05% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 1.55% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 25.99% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 23.86% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -73.26% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | -11.69% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 8.59% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | -20.63% |
| 10 | Veracyte | 3.68 Bn | 3.38 Bn | 108.55 Mn | 10.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.71% |
| Mar 31, 2026 | 60.21% |
| Dec 31, 2025 | 90.65% |
| Sep 30, 2025 | 53.77% |
| Jun 30, 2025 | 27.82% |
| Mar 31, 2025 | 96.38% |
| Dec 31, 2024 | 137.15% |
| Sep 30, 2024 | 281.15% |
| Jun 30, 2024 | 4.40% |
| Mar 31, 2024 | -17.30% |
| Dec 31, 2023 | 40.93% |
| Sep 30, 2023 | 284.59% |
| Jun 30, 2023 | -38.14% |
| Mar 31, 2023 | -0.39% |
| Dec 31, 2022 | 33.81% |
| Sep 30, 2022 | 44.98% |
| Jun 30, 2022 | 33.17% |
| Mar 31, 2022 | -6.30% |
| Dec 31, 2021 | 188.72% |
| Sep 30, 2021 | 28.74% |